The predictive impact of body mass index on the efficacy of extended adjuvant endocrine treatment with anastrozole in postmenopausal patients with breast cancer: an analysis of the randomised ABCSG-6a trial

Efficacy of tamoxifen±aminoglutethimide in normal weight and overweight postmenopausal patients with hormone receptor-positive breast cancer: an analysis of 1509 patients of the ABCSG-06 trial

(2013) G Pfeiler et al.   BRITISH JOURNAL OF CANCER

Suppression of Plasma Estrogen Levels by Letrozole and Anastrozole Is Related to Body Mass Index in Patients With Breast Cancer

(2012) Elizabeth J. Folkerd et al.   JOURNAL OF CLINICAL ONCOLOGY

Endocrine therapy in obese patients with primary breast cancer: another piece of evidence in an unfinished puzzle

(2011) R. Wolters et al.   BREAST CANCER RESEARCH AND TREATMENT

Pre-diagnosis body mass index and survival after breast cancer in the After Breast Cancer Pooling Project

(2011) Marilyn L. Kwan et al.   BREAST CANCER RESEARCH AND TREATMENT

High non-compliance in the use of letrozole after 2.5years of extended adjuvant endocrine therapy. Results from the IDEAL randomized trial

(2011) D.B.Y. Fontein et al.   EJSO

Impact of Body Mass Index on the Efficacy of Endocrine Therapy in Premenopausal Patients With Breast Cancer: An Analysis of the Prospective ABCSG-12 Trial

(2011) Georg Pfeiler et al.   JOURNAL OF CLINICAL ONCOLOGY

Insulin- and Obesity-Related Variables in Early-Stage Breast Cancer: Correlations and Time Course of Prognostic Associations

(2011) Pamela J. Goodwin et al.   JOURNAL OF CLINICAL ONCOLOGY

Prevalence and Trends in Obesity Among US Adults, 1999-2008

(2010) Katherine M. Flegal   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

American Society of Clinical Oncology Clinical Practice Guideline: Update on Adjuvant Endocrine Therapy for Women With Hormone Receptor–Positive Breast Cancer

(2010) Harold J. Burstein et al.   JOURNAL OF CLINICAL ONCOLOGY

Effect of Body Mass Index on Recurrences in Tamoxifen and Anastrozole Treated Women: An Exploratory Analysis From the ATAC Trial

(2010) Ivana Sestak et al.   JOURNAL OF CLINICAL ONCOLOGY

Effect of Obesity on Prognosis After Early-Stage Breast Cancer

(2010) Marianne Ewertz et al.   JOURNAL OF CLINICAL ONCOLOGY

Extended Adjuvant Endocrine Therapy in Breast Cancer: Current Status and Future Directions

(2008) Paul E. Goss et al.   Clinical Breast Cancer

Benefit From Exemestane As Extended Adjuvant Therapy After 5 Years of Adjuvant Tamoxifen: Intention-to-Treat Analysis of the National Surgical Adjuvant Breast and Bowel Project B-33 Trial

(2008) Eleftherios P. Mamounas et al.   JOURNAL OF CLINICAL ONCOLOGY